Stock·NASDAQ·Industrials
American Airlines Group Inc. (AAL)
- Market cap
- $7.86B
- Dividend yield
- None (suspended)
- Street target
- $15.00median of 25 analysts
- 52-week range
- $10.09 $18.79
The short version
Where AAL stands today, in four lines, and what CleaRank Financial AI makes of it.
AAL at a glance
American Airlines Group Inc. (AAL): Sell, 38/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($13.42 and $13.69).
- Earnings AAL beat estimates in 7 of its last 7 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $7.0M and made no open-market purchases over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates American Airlines Group Inc. (AAL) Sell, with a model score of 38/100.
The analysts' outlook lifts the score most: the median target is 26.3% above the price. The trend holds it back most: the price is 13.27% below its 200-day average and 11.50% below its 50-day average, and the 50-day average is 2.00% below the 200-day. The 50-day average stands at $13.42 and the 200-day at $13.69. Over the past year the price fell 0.08%.
Only on CleaRank
Figures we compute ourselves from AAL's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $11.88 is 11.5% below the 50-day simple moving average of $13.42.Price above its 200-day average ›
The price is 13.3% below the 200-day simple moving average of $13.69.50-day average above the 200-day ›
The 50-day average ($13.42) is 2.0% below the 200-day average ($13.69), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 21% of its 52-week range, between $10.09 and $18.79.
AAL share price
Pick a period: each tab shows how far AAL has moved over it, to the last close.
Today's trading
Where AAL sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/3P/S below the sector median ›
The price-to-sales ratio of 0.14 is 96.5% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $-326.0M on revenue of $58.3B, a net margin of -0.6%.Beat estimates in most recent reports ›
AAL beat the EPS estimate in 7 of its last 7 reports.
Key statistics
The headline figures for AAL.
As of October 17, 2026, AAL trades at $11.88, with a market value of $7.86B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of AAL's valuation, growth and risks.
AAL's P/E cannot be read, since it is not meaningful because the company lost money over the last 12 months. Its price-to-sales ratio of 0.14 is 96.5% below the sector median of 4.0. The company's market capitalisation stands at $7.9B.
American Airlines Group Inc. is not making money right now: its net margin is -0.56% and its operating margin is 2.81%. Return on equity stands at -2.98%, below the sector median of 17.8%. On the top line, revenue expanded 16.30% in the latest year, a faster pace than the sector median of 11.7%. No dividend is reported in our data.
AAL beat the estimate by 200.00% in its last earnings report, released on July 23, 2026. The company posted $0.15 a share against an estimate of $0.05. Investors responded well, and the stock rose 6.78% in the following session.
The record is a clean sweep: 7 beats in 7 reports, though the stock still fell in the first session after 1 of those 7 beats. The consensus EPS estimate stands at -$0.8207 for this fiscal year and $1.49 for next, a decline of 328.0% for the current year.
AAL's average daily move is 2.16%. The trend works against holders until the price reclaims its moving averages. At $18.79, the 52-week high sits well above the current price, which is 36.80% below it. Insiders sold $7.0M of stock over the last 18 months and bought none on the open market. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than purchases would.
AAL against the Industrials sector
How AAL compares with the median Industrials stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, AAL trades at 0.1393x, far below the sector average of 4.00x.
Return vs XLI: Since May 6, 2025, AAL has gained 13.9% against a gain of 25.6% for XLI.
Performance against XLI
AAL and the Industrials sector fund over the same days.
Revenue and earnings
How much AAL sells, and how much of it becomes profit.
Revenue growth: Revenue grew 0.8% in FY2025 to $54.6B, from $54.2B a year earlier.
Profit margin: The net margin was 0.2% in FY2025, down from 1.6% the year before.
Profitable: AAL earned $111M in FY2025.
Earnings reality check
Did AAL beat what analysts expected, and how did the stock react?
Earnings record: AAL beat the analyst estimate in 7 of the last 7 quarters.
Market reaction: The stock fell in the first session after 1 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 23, 2026after close | $0.05 | $0.15 | +200.00% | +6.78% | +13.79% |
| Apr 23, 2026after close | -$0.46 | -$0.40 | +13.04% | +2.72% | -0.59% |
| Oct 23, 2025after close | -$0.28 | -$0.17 | +39.29% | +7.91% | +0.08% |
| Jul 24, 2025after close | $0.77 | $0.95 | +23.38% | +0.35% | +0.26% |
| Apr 24, 2025after close | -$0.67 | -$0.59 | +11.94% | +1.46% | +4.37% |
| Jan 23, 2025after close | $0.66 | $0.86 | +30.30% | -0.41% | -0.76% |
| Oct 24, 2024after close | $0.17 | $0.30 | +76.47% | +2.90% | +4.85% |
As of October 17, 2026, AAL has beaten the analyst EPS estimate in 7 of its last 7 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on July 23, 2026, came in 200.00% above the estimate and the stock moved +6.78% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 33.7, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 33.7 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of AAL
The score, the reasoning behind it, and what could move the price next.
AAL is in a downtrend. Trading at $11.88, the stock sits 11.50% below its 50-day average of $13.42 and 13.27% below its 200-day average of $13.69. Near the bottom of its 52-week range, the price is 17.69% above the low of $10.09, while sitting 36.80% below the high of $18.79. Both averages point the same way, with the 50-day 2.00% below the 200-day.
The 14-day RSI of 33.7 is in the bearish zone, above the oversold line, and the MACD line is negative. The record is negative across every period shown: the price fell 20.69% over the past three months, fell 7.04% over the past six months and fell 0.08% over the past year. Volume in the last session ran 31.8% below its average, on a day the price fell 3.30%.
Earnings beat ›
The July 23, 2026 report beat the EPS estimate by 200.00%, and the share price rose 6.78% in the first session after it.
Source: Earnings report, July 23, 2026
Rating reaffirmed ›
Susquehanna kept its Positive rating on October 7, 2026.
Source: Analyst action, Susquehanna, October 7, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $12.77 sits above the price, and the 52-week low at $10.09 sits below it.
- The 14-day RSI reads 33.7, in the bearish zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- AAL's share price rose 6.78% in the first session after the July 23, 2026 report. The company has beaten estimates in 7 of its last 7 reports.
The trend for AAL is down because the price sits under both its 50-day ($13.42) and 200-day ($13.69) averages. A recovery would first show up as a move back above the 50-day. The closest level overhead is the 20-day EMA at $12.77.
The next level below the price is the 52-week low at $10.09. With the RSI in the bearish zone, momentum still leans toward lower prices.
Technical indicators
Momentum and trend for AAL, from its daily closes.
As of October 17, 2026, with AAL at $11.88, its 14-day RSI is 33.7 (showing bearish momentum without being oversold), its 50-day simple moving average is $13.42 and its 200-day is $13.69.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What AAL moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, AAL's 1-year correlation of daily returns is +0.54 with S&P 500 (SPY), +0.48 with Nasdaq 100 (QQQ), +0.21 with Bitcoin (BTC) and +0.07 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
12 of 25 analysts rate it a buy or strong buy, 11 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $15.00 is 26.3% above the price.More buy ratings than three months ago ›
12 of 25 rate it a buy now, against 12 of 25 three months ago.
AAL Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 7, 2026 | Susquehanna | Maintains | Positive |
| Oct 6, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Oct 2, 2026 | Goldman Sachs | Maintains | Sell |
| Oct 2, 2026 | TD Cowen | Maintains | Buy |
| Sep 28, 2026 | BMO Capital | Maintains | Market Perform |
| Sep 28, 2026 | Evercore ISI Group | Maintains | In-Line |
As of October 17, 2026, 25 Wall Street analysts cover AAL: 12 rate it a buy or strong buy, 11 a hold and 2 a sell or strong sell. Their 12-month price targets range from $10.30 to $24.00, with a median of $15.00, 26.3% above the price of $11.88.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
AAL trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from AAL's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much AAL tends to move, against the market and on its own.
The long record
AAL's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 2.16% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 84.1%, from January 2018 to May 2020; the price is still 79.1% below that peak.Most 1-year holds ended higher ›
35% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $3,192.98, against $42,058 in the S&P 500 (SPY).
AAL Drawdowns & Recovery
As of October 17, 2026, AAL's worst peak-to-trough fall over the last 10 years with dividends reinvested was -84.1% (January 2018 to May 2020); it is still 79.1% below that peak, and 35% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into AAL in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: AAL trailed the S&P 500 over this period: $3,192.98 against $42,058.
A $10,000 investment in AAL in October 2016 would be worth about $3,193 today with dividends reinvested, compared with about $42,058 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to AAL, and which have not.
Strongest month, November: an average of +9.92%, up in 8 of 10 years.
Weakest month, March: an average of -9.44%, up in 2 of 10 years.
This month, October: has averaged +0.95%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, AAL's strongest calendar month has been November (average +9.92%, up in 8 of 10 years) and its weakest March (average -9.44%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in AAL, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in AAL today could grow to about $7,083 by 2036 in the base case, with a 90th-percentile outcome near $53,740 and a 10th-percentile outcome around $934. Projections are statistical simulations, not guarantees.
AAL Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $10.35 for AAL by 2030 in the base case, from $11.88 today (0.9x over 4 years). The 10th-percentile path ends near $2.87. These are outcomes of a Monte Carlo simulation run on AAL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $6.04 | $11.47 | $21.77 | |
| 2028 | $4.48 | $11.08 | $27.43 | |
| 2029 | $3.53 | $10.71 | $32.49 | |
| 2030 | $2.87 | $10.35 | $37.27 | |
| 2031 | $2.38 | $9.99 | $41.88 |
Method: a lognormal simulation of AAL's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
AAL insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought AAL shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, AAL insiders reported 7 open-market sales worth $7.0M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 31, 2026 | Stephen L Johnson
Officer
|
Sell | 60.0K | $916.7K |
| Jul 31, 2026 | Angela Owens
Officer
|
Sell | 40.1K | $611.6K |
| Jul 29, 2026 | Stephen L Johnson
Officer
|
Sell | 90.0K | $1.3M |
| Jul 28, 2026 | Angela Owens
Officer
|
Sell | 39.2K | $601.0K |
| Jul 15, 2026 | John W Dietrich
Director
|
Grant | 8.7K | - |
| Jun 25, 2026 | David Seymour
Chief Operating Officer
|
Sell | 125.8K | $2.2M |
| Jun 10, 2026 | Adriane M Brown
Director
|
Grant | 11.2K | - |
| Jun 10, 2026 | John T Cahill
Director
|
Grant | 11.2K | - |
| Jun 10, 2026 | Mary N Dillon
Director
|
Grant | 11.2K | - |
| Jun 10, 2026 | Kathryn M Farmer
Director
|
Grant | 11.2K | - |
| Jun 10, 2026 | Matthew J Hart
Director
|
Grant | 11.2K | - |
| Jun 10, 2026 | Susan D Kronick
Director
|
Grant | 11.2K | - |
| Jun 10, 2026 | Martin H Nesbitt
Director
|
Grant | 11.2K | - |
| Jun 10, 2026 | Vicente Reynal
Director
|
Grant | 11.2K | - |
| Jun 10, 2026 | Gregory D Smith
Director
|
Grant | 26.1K | - |
| Jun 10, 2026 | Douglas M Steenland
Director
|
Grant | 11.2K | - |
| Jun 10, 2026 | Howard I. Ungerleider
Director
|
Grant | 11.2K | - |
| Mar 24, 2026 | Mary N Dillon
Director
|
Grant | 3.0K | - |
| Feb 17, 2026 | Robert D Isom Jr
Chief Executive Officer
|
Grant | 781.3K | - |
| Feb 17, 2026 | Stephen L Johnson
Officer
|
Grant | 442.7K | - |
| Feb 17, 2026 | Devon E May
Chief Financial Officer
|
Grant | 311.1K | - |
| Feb 17, 2026 | Angela Owens
Officer
|
Grant | 100.6K | - |
| Feb 17, 2026 | Nathaniel Pieper
Officer
|
Grant | 216.7K | - |
| Feb 17, 2026 | Anthony J. Richmond
Officer
|
Grant | 241.6K | - |
| Feb 17, 2026 | David Seymour
Chief Operating Officer
|
Grant | 321.8K | - |
| Dec 16, 2025 | David Seymour
Chief Operating Officer
|
Sell | 25.6K | $409.7K |
| Dec 9, 2025 | David Seymour
Chief Operating Officer
|
Sell | 62.5K | $938.3K |
| Nov 3, 2025 | Nathaniel Pieper
Officer
|
Grant | 22.5K | - |
| Aug 18, 2025 | Devon E May
Chief Financial Officer
|
Grant | 151.9K | - |
| Aug 18, 2025 | David Seymour
Chief Operating Officer
|
Grant | 151.9K | - |
| Jun 11, 2025 | Adriane M Brown
Director
|
Grant | 13.6K | - |
| Jun 11, 2025 | John T Cahill
Director
|
Grant | 13.6K | - |
| Jun 11, 2025 | Kathryn M Farmer
Director
|
Grant | 13.6K | - |
| Jun 11, 2025 | Matthew J Hart
Director
|
Grant | 13.6K | - |
| Jun 11, 2025 | Susan D Kronick
Director
|
Grant | 13.6K | - |
| Jun 11, 2025 | Martin H Nesbitt
Director
|
Grant | 13.6K | - |
| Jun 11, 2025 | Leary Denise M O
Director
|
Grant | 13.6K | - |
| Jun 11, 2025 | Vicente Reynal
Director
|
Grant | 13.6K | - |
| Jun 11, 2025 | Gregory D Smith
Director
|
Grant | 31.6K | - |
| Jun 11, 2025 | Douglas M Steenland
Director
|
Grant | 13.6K | - |
| Jun 11, 2025 | Howard I. Ungerleider
Director
|
Grant | 13.6K | - |
| May 1, 2025 | Anthony J. Richmond
Officer
|
Grant | 832.5K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.